Koers Cell Therapeutics Inc Nasdaq
Aandelen
US1509346029
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
2023 | Sobi rondt overname van CTI BioPharma af voor $1,7 miljard | MT |
2023 | Swedish Orphan Biovitrum rondt bod op CTI BioPharma af | MT |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20-03-17 |
David Kirske
DFI | Director of Finance/CFO | 69 | 01-08-17 |
John Volpone
HRO | Human Resources Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20-03-17 |
David Parkinson
BRD | Director/Board Member | 73 | 05-06-17 |
Reed Tuckson
BRD | Director/Board Member | 73 | 01-09-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,60% | 51,07 mld. | |
-7,64% | 38,78 mld. | |
+35,88% | 38,61 mld. | |
-10,62% | 27,32 mld. | |
+11,87% | 26,35 mld. | |
-17,38% | 19,46 mld. | |
+41,13% | 13,58 mld. | |
+30,50% | 12,46 mld. | |
-2,93% | 11,75 mld. |
- Beurs
- Aandelen
- Koers CTIC
- Koers